Among those with advanced gastric cancer, oral Liporaxel showed superior overall survival outcomes versus IV Liporaxel as a ...

Research into ENA-001 is also supported by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) under award number R44DA057133. The content of this document is the ...

Panelists discuss how oral iron therapy, although convenient and cost-effective, has significant limitations, including ...

Although the disease has left him shaken and he still experiences some weakness, Pawar is now back home with his family and is trying to get back to his normal life.

Panelists discuss how modern FDA-approved intravenous iron formulations, including ferric carboxymaltose, ferumoxytol, and ...

Dr. Eric K. Singhi shares his insights into the advantages of the subcutaneous formulation of Opdivo versus the IV version ...

Funding from the NIH's National Institute on Drug Abuse (NIDA) will Support Development of ENA-001, an Agnostic Respiratory Stimulant, for Community Drug Overdose and as a Medical ...

Oral paclitaxel matched IV in progression-free survival but outperformed it in overall survival for second-line advanced gastric cancer.

The Philippine Dermatological Society (PDS) again reminded the public on Monday that injectable glutathione is not approved ...

The Food and Drug Administration said Tuesday that no IV glutathione product in the Philippines was approved for skin whitening.

NPPA seeks market-based price data on four IVs for ceiling price fixation: Gireesh Babu, New Delhi Saturday, January 25, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pricing ...

LOVELAND, CO, UNITED STATES, January 29, 2025 /EINPresswire / -- The newly opened Suite Health infusion clinic provides personalized infusion therapy options for clients seeking targeted infusion ...